1971
DOI: 10.1016/s0022-5347(17)61385-5
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of Stage 1 Carcinoma of the Prostate: A Preliminary Report

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

1981
1981
2002
2002

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 52 publications
(6 citation statements)
references
References 15 publications
0
6
0
Order By: Relevance
“…The patients with focal lesion require no further therapy and perhaps no further follow-up [25]. It has been suggested also that repeated transurethral resection should be done to determine whether unre The reported frequencies of the different histologic grades for T0 cases vary remarkable: the incidence of well-differentiated tumors is on the average 60%, about 10% of which are poorly differentiated [20][21][22]. In the present material 59% of the cases were highly and 6% poorly differentiated tumors.…”
Section: Discussionmentioning
confidence: 57%
“…The patients with focal lesion require no further therapy and perhaps no further follow-up [25]. It has been suggested also that repeated transurethral resection should be done to determine whether unre The reported frequencies of the different histologic grades for T0 cases vary remarkable: the incidence of well-differentiated tumors is on the average 60%, about 10% of which are poorly differentiated [20][21][22]. In the present material 59% of the cases were highly and 6% poorly differentiated tumors.…”
Section: Discussionmentioning
confidence: 57%
“…Only 6 (13.0%) patients underwent subsequent radical prostatectomy with pelvic lymphadenectomy, including 5 at stage Al and 1 at stage A2, and residual tumors were identified in 4 patients (66.7%). Previous reports of patients with stage A carcinoma treated by radical pros tatectomy have shown that 50 to 87.5% have residual tumor in the surgical specimen [15][16][17], The high rate of residual tumor indicates that patients with stage A dis ease are not entirely free of the risk of progression. So, further aggressive therapy should be considered.…”
Section: Discussionmentioning
confidence: 99%
“…Unfortunately, a high risk of thromboem bolic complications is a clinically important adverse effect of estrogen therapy [1][2][3][4][5]. The exact mechanism responsible for the increased risk of thromboembolism is not known.…”
Section: Introductionmentioning
confidence: 99%